CN101289478B - 一种红景天苷的分离制备方法 - Google Patents
一种红景天苷的分离制备方法 Download PDFInfo
- Publication number
- CN101289478B CN101289478B CN2007100110393A CN200710011039A CN101289478B CN 101289478 B CN101289478 B CN 101289478B CN 2007100110393 A CN2007100110393 A CN 2007100110393A CN 200710011039 A CN200710011039 A CN 200710011039A CN 101289478 B CN101289478 B CN 101289478B
- Authority
- CN
- China
- Prior art keywords
- concentrated
- rhodioside
- separating
- ethanol
- millimeters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 title abstract description 5
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 title abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 58
- 241001165494 Rhodiola Species 0.000 claims abstract description 36
- 239000012528 membrane Substances 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 17
- 238000001556 precipitation Methods 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims description 20
- 238000010828 elution Methods 0.000 claims description 15
- 238000004587 chromatography analysis Methods 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 238000005057 refrigeration Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 8
- 230000005526 G1 to G0 transition Effects 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000012488 sample solution Substances 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 7
- 238000000926 separation method Methods 0.000 abstract description 5
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 12
- 238000002390 rotary evaporation Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 8
- 241000209094 Oryza Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 238000000825 ultraviolet detection Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ILRCGYURZSFMEG-RKQHYHRCSA-N Salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RKQHYHRCSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- JUJWROOIHBZHMG-RALIUCGRSA-N pyridine-d5 Chemical compound [2H]C1=NC([2H])=C([2H])C([2H])=C1[2H] JUJWROOIHBZHMG-RALIUCGRSA-N 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
序号 | 时间(min) | 流量(ml/min) | A:甲醇(%) | B:水(%) |
1 | 0 | 200 | 5 | 95 |
2 | 10 | 200 | 5 | 95 |
3 | 25 | 200 | 30 | 70 |
4 | 40 | 200 | 35 | 65 |
5 | 55 | 200 | 60 | 40 |
6 | 60 | 200 | 100 | 0 |
7 | 75 | 200 | 100 | 0 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100110393A CN101289478B (zh) | 2007-04-20 | 2007-04-20 | 一种红景天苷的分离制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100110393A CN101289478B (zh) | 2007-04-20 | 2007-04-20 | 一种红景天苷的分离制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101289478A CN101289478A (zh) | 2008-10-22 |
CN101289478B true CN101289478B (zh) | 2011-04-20 |
Family
ID=40033946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100110393A Active CN101289478B (zh) | 2007-04-20 | 2007-04-20 | 一种红景天苷的分离制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101289478B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603819A (zh) * | 2011-01-25 | 2012-07-25 | 苏州宝泽堂医药科技有限公司 | 一种洛塞维的制备方法 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101955501B (zh) * | 2010-10-19 | 2012-08-22 | 北京大学 | 一种中试规模提取分离高纯度红景天苷的方法 |
CN104510755A (zh) * | 2014-11-11 | 2015-04-15 | 济南星懿医药技术有限公司 | 一种抗病毒的药物组合物 |
CN105294789B (zh) * | 2015-12-08 | 2018-05-25 | 四川艾丽碧丝制药有限公司 | 一种高纯度红景天苷的制备方法 |
CN106117278A (zh) * | 2016-06-14 | 2016-11-16 | 南京华宽信息咨询中心 | 一种红景天苷的提取方法及红景天苷提取物 |
CN106083949A (zh) * | 2016-06-17 | 2016-11-09 | 延边大学 | 一种提高红景天苷提取率的方法 |
CN107811179A (zh) * | 2017-10-24 | 2018-03-20 | 青海鑫池源生物科技开发有限公司 | 一种红景天饮料及其制备方法 |
CN113101311B (zh) * | 2021-05-28 | 2022-03-22 | 浙江大学 | 红景天活性组分及其在制备治疗心肌肥厚药物中的应用 |
CN114748894A (zh) * | 2021-11-08 | 2022-07-15 | 天津中科博蕴生物技术有限公司 | 一种硅胶键合填料分离红景天苷的方法 |
CN114522176A (zh) * | 2022-03-21 | 2022-05-24 | 武汉佳牧生物科技有限公司 | 红景天苷在制备抗犬细小病毒制剂或药物中的应用 |
-
2007
- 2007-04-20 CN CN2007100110393A patent/CN101289478B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603819A (zh) * | 2011-01-25 | 2012-07-25 | 苏州宝泽堂医药科技有限公司 | 一种洛塞维的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101289478A (zh) | 2008-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101289478B (zh) | 一种红景天苷的分离制备方法 | |
CN101723998B (zh) | 一种黄芩中黄酮苷的制备方法 | |
CN101289480B (zh) | 一种甘草苷的分离制备方法 | |
CN105566414B (zh) | 从杨梅果肉中分离纯化四种黄酮糖苷的方法 | |
CN101863871A (zh) | 蔷薇红景天总苷及其医药用途和制备方法 | |
CN101289429B (zh) | 一种表告依春的分离制备方法 | |
CN103819445A (zh) | 小叶莲中两个具有降血脂活性的新异戊烯基化黄酮类化合物的制备方法 | |
CN110437053B (zh) | 一种从紫茎泽兰中提取分离泽兰酮类化合物的方法 | |
CN110526952B (zh) | 一种粗糙凤尾蕨中提取黄酮苷的制备方法 | |
CN102180938A (zh) | 细梗香草皂苷的制备方法 | |
CN101050226A (zh) | 一种牡荆素衍生物分离方法 | |
CN103830306B (zh) | 一种忍冬叶有效提取物的制备方法 | |
CN104829474B (zh) | 一种从枸杞叶中制备甜菜碱化学对照品的方法 | |
CN102898347A (zh) | 一种从小叶锦鸡儿中萃取海帕刺桐碱的方法 | |
CN106674309B (zh) | 香豆素苷类化合物及其制备方法和应用 | |
CN104645667B (zh) | 扩张床色谱与逆流色谱在线联用方法、应用及装置 | |
CN107721857A (zh) | 一种从平卧菊三七中制备高纯度绿原酸的方法 | |
CN105294789B (zh) | 一种高纯度红景天苷的制备方法 | |
CN104892620B (zh) | 一种高纯度水黄皮素的制备方法 | |
CN107200760A (zh) | 一种高纯度红镰霉素-6-O-β-龙胆二糖苷的制备方法 | |
CN103588826B (zh) | 一种复方丹参浸膏中低聚四糖的分离纯化方法 | |
CN106674299B (zh) | 聚炔苷类化合物及其制备方法和应用 | |
CN110862399A (zh) | 一种从汉防己总碱中制取汉防己甲素的方法 | |
CN101747392B (zh) | 一种朝藿定c化学对照品的分离制备方法 | |
CN103242399A (zh) | 一种从构树叶中提取芹菜素-7-O-β-D-葡萄糖醛酸苷的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WENZHOU HUAPU MATERIAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES Effective date: 20141222 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 116023 DALIAN, LIAONING PROVINCE TO: 317503 TAIZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141222 Address after: 317503 No. 8, foreshore Road, Jingang Port Development Zone, Binhai Town, Zhejiang, Wenling, China Patentee after: Wenling spectrum Mstar Technology Ltd Address before: 116023 Zhongshan Road, Liaoning, No. 457, Patentee before: Dalian Institute of Chemical Physics, Chinese Academy of Sciences |
|
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG ACCHROM INNOVATION TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WENZHOU HUAPU MATERIAL TECHNOLOGY CO., LTD. Effective date: 20150106 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150106 Address after: 317503 No. 1, foreshore Road, Jingang Port Development Zone, Binhai Town, Zhejiang, Wenling, China Patentee after: ZHEJIANG ACCHROM TECHNOLOGIES CO., LTD. Address before: 317503 No. 8, foreshore Road, Jingang Port Development Zone, Binhai Town, Zhejiang, Wenling, China Patentee before: Wenling spectrum Mstar Technology Ltd |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for separation and preparation of Salidroside Effective date of registration: 20210625 Granted publication date: 20110420 Pledgee: Zhejiang Wenling Rural Commercial Bank Co.,Ltd. Pledgor: Zhejiang Huapu Xinchuang Technology Co.,Ltd. Registration number: Y2021330000676 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |